Overview

Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate Homeostasis

Status:
Not yet recruiting
Trial end date:
2028-02-28
Target enrollment:
Participant gender:
Summary
This study will be the first in vivo human multimodal neuroimaging study exploring the relationship between mGluR5 availability (PET), neural oscillations (EEG), and cognitive function in people with CUD. The goal is to test the overall hypothesis that mGluR5 availability is higher in people with CUD compared with HC. In Aim 1, the investigators will determine differences in mGluR5 availability between people with CUD and HC in the fronto-limbic brain circuit. Aim 2 examines the associations between mGluR5 availability, CUD severity, neural oscillations, and cognitive function in CUD subjects. Aim 3 will determine how prolonged abstinence from chronic cannabis use affects mGluR5 availability, neural oscillations, and cognitive function in CUD subjects.
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Drug Abuse (NIDA)